APFM Section 2 Module 5: Special Considerations and Hot Topics
Module Description
Target Audience
Pharmacists, Pharmacy Technicians, Managed Care Professionals
Learning Objectives
At the completion of this activity, participants should be able to:
- Define different FDA accelerated approval pathways and their implications on formulary management.
- Discuss considerations for incorporating biosimilars, digital therapeutics, and high-investment therapies into a formulary.
- Recognize health disparities and their influence on healthcare access and affordability.
- Identify methods for collecting and integrating patient feedback into formulary management practices.
- Summarize value-based care models and its impact on outcomes-based reimbursement and population health management.
Faculty:
Spenser Smith, PharmD
Senior Clinical Pharmacist
Blue Cross Blue Shield of North Carolina
Financial Relationship Disclosures:
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
Spenser Smith, PharmD Faculty | None |
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
Accreditation:
ACPE UAN:0233-0000-23-026-H04-P • Activity Type: Knowledge-Based
Contact Hours: 0.75
Release Date: August 04, 2023 • Expiration Date: July 31, 2026
CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.